Equities

Oxford Biomedica PLC

OXB:LSE

Oxford Biomedica PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)215.00
  • Today's Change2.50 / 1.18%
  • Shares traded91.06k
  • 1 Year change-52.17%
  • Beta1.3527
Data delayed at least 20 minutes, as of Apr 23 2024 13:59 BST.
More ▼

IC View

The last IC recommendation on Oxford Biomedica PLC shares was Hold at 266.00 on 21 Sep 2023Read the full article

Key statistics

As of last trade, Oxford Biomedica PLC (OXB:LSE) traded at 215.00, 30.87% above the 52 week low of 164.29 set on Dec 01, 2023.
52-week range
Today
164.29Dec 01 2023474.50Jun 15 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open215.50
High219.00
Low213.00
Bid213.50
Offer215.00
Previous close212.50
Average volume251.51k
Shares outstanding100.00m
Free float80.81m
P/E (TTM)--
Market cap212.50m GBP
EPS (TTM)-0.6389 GBP
Data delayed at least 20 minutes, as of Apr 23 2024 13:59 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.